Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine
- 1 January 1991
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 65 (1) , 308-312
- https://doi.org/10.1128/jvi.65.1.308-312.1991
Abstract
We selected 39-azido-39-deoxythymidine (AZT)-resistant mutants of feline immunodeficiency virus (FIV) in a cat cell culture system. The characterization of one of these mutants was facilitated by the development of a focal immunoassay which could accurately measure FIV infectivity. This assay was used to quantitate the susceptibility of FIV to various inhibitors. The AZT-resistant mutant was found to be cross-resistant to 39-azido-29,39-dideoxyuridine and 39-azido-29,39-dideoxyguanosine but remained sensitive to several other inhibitors (29,39-dideoxyinosine, 29,39-dideoxy-29,39-didehydrothymidine, and phosphonoformate). These patterns of cross-resistance and sensitivity were similar to those of the AZT-resistant human immunodeficiency virus (HIV) that has recently been isolated from patients with AIDS (B. A. Larder and S. D. Kemp, Science 246:1155-1158, 1989). Like the AZT-resistant HIV, purified reverse transcriptase from mutant FIV failed to show resistance to the 59-triphosphate of AZT. This mutant can be used in the FIV model system to study the mechanisms of drug resistance and to determine the pathogenicity of AZT-resistant mutants. ImagesKeywords
This publication has 16 references indexed in Scilit:
- Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency virusesAntimicrobial Agents and Chemotherapy, 1990
- Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assayAntimicrobial Agents and Chemotherapy, 1990
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.Proceedings of the National Academy of Sciences, 1989
- Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndromeAntimicrobial Agents and Chemotherapy, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Site-specific mutagenesis of AIDS virus reverse transcriptaseNature, 1987
- Isolation of a T-Lymphotropic Virus from Domestic Cats with an Immunodeficiency-Like SyndromeScience, 1987
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985